articles by Biplob Borthakur


Unregulated use of plasma therapy for COVID-19 can be harmful, writes expert; can expose patients to serious transfusion-related risks

It is a promising solution at the present gloomy situation, but till we have reliable evidence on utility unregulated use is to be avoided


Extension of coronavirus lockdown without ensuring access to healthcare for non-COVID-19 patients may defeat efforts to avoid collateral damage

India has a whopping 54.6 million people with heart disease, 83 people per lakh population have cancer.